Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

AGM Trading update

28 Mar 2024 07:00

RNS Number : 5857I
IDOX PLC
28 March 2024
Β 

28 March 2024

Idox plc

('Idox'Β orΒ theΒ 'Group'Β orΒ theΒ 'Company')

AGM Trading update

Good momentum continues in the current financial year

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and geospatial data solutions to the public and asset-intensive sectors, is pleased to issue a trading update for the period from 1 November 2023 to date, ahead of today's Annual General Meeting.

Highlights during the period include:

Β· Operational and financial performance continue to be in line with the Board's expectations and we remain confident about the outlook for the year.

Β· High levels of recurring revenue, contract renewals, orderbook and pipeline provide good visibility, leaving Idox well placed to grow by double digits in FY24.

Β· With a strong foundation in property and asset-based solutions and data services we continue to enhance and grow our capabilities across the Group.

Β· The integration of Emapsite (acquired August 2023) is progressing well and in line with our expectations.

Β· Idox has an attractive M&A pipeline with significant financial resources for larger, accretive and enhancing acquisitions at appropriate valuations.

A further trading update will be issued following the half year ending 30 April 2024.

David Meaden, Chief Executive Officer, said:

"We remain confident that Idox is well positioned for growth in FY24 and beyond. The Group has made a good start to the year and continues to trade in line with the Board's expectations. Our focus on securing high quality recurring revenue and repeatable services provides confidence in delivering double digit growth in FY24. We have a healthy balance sheet and are confident we can maximise the opportunities for profitable organic and inorganic growth whilst remaining resilient to the current macro-economic challenges."

For further information please contact:

Idox plc

+44 (0) 870 333 7101

Chris Stone, Non-Executive Chairman

investorrelations@idoxgroup.com

David Meaden, Chief Executive

Β 

Anoop Kang, Chief Financial Officer

Β 

Β 

Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900

Paul Gillam

Β 

Adam Telling

Β 

Β 

MHP

+ 44 (0) 20 3128 8100

Reg Hoare

Β idox@mhpgroup.com

Ollie Hoare

Matthew Taylor

Β 

About Idox plc

For more information seeΒ www.idoxplc.com @Idoxgroup

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTBRGDXRDDDGSR
Date   Source Headline
24th Apr 20184:32 pmRNSHolding(s) in Company
24th Apr 201810:24 amRNSHolding(s) in Company
23rd Apr 20183:40 pmRNSHolding(s) in Company
19th Apr 20183:58 pmRNSResult of AGM and Board Change
19th Apr 20183:54 pmRNSAGM Statement and Trading Update
19th Apr 20187:00 amRNSAGM Statement and Trading Update
27th Mar 20185:17 pmRNSDirector/PDMR Shareholding
27th Mar 201811:02 amRNSPosting of Annual Report and Notice of AGM
22nd Mar 20185:27 pmRNSHolding(s) in Company
19th Mar 201811:22 amRNSHolding(s) in Company
15th Mar 20185:17 pmRNSVesting of LTIP
8th Mar 20184:43 pmRNSHolding(s) in Company
1st Mar 201812:25 pmRNSDirectorate Change
1st Mar 201811:30 amRNSHolding(s) in Company
1st Mar 20187:00 amRNSFinal Results
20th Feb 201812:24 pmRNSHolding(s) in Company
2nd Feb 20184:12 pmRNSHolding(s) in Company
2nd Feb 20188:58 amRNSHolding(s) in Company
31st Jan 20184:52 pmRNSHolding(s) in Company
25th Jan 201812:34 pmRNSDirector/PDMR Shareholding
5th Jan 20184:40 pmRNSSecond Price Monitoring Extn
5th Jan 20184:35 pmRNSPrice Monitoring Extension
3rd Jan 201810:51 amRNSHolding(s) in Company
27th Dec 20171:48 pmRNSHolding(s) in Company
13th Dec 20177:00 amRNSYear End Update and Board Change
14th Nov 20173:45 pmRNSYear End Trading Update
2nd Nov 20171:31 pmRNSDirector Update
22nd Sep 20172:33 pmRNSExercise of Options and Total Voting Rights
20th Sep 20179:32 amRNSHolding(s) in Company
4th Sep 201710:38 amRNSDirectors' Dealing, Exercise of Options & TVR
1st Sep 20176:16 pmRNSHolding(s) in Company
23rd Aug 20176:06 pmRNSHolding(s) in Company
17th Aug 20177:00 amRNSAcquisition
4th Aug 20174:20 pmRNSDirector and PCA Dealing
14th Jul 20173:52 pmRNSDirector/PDMR Shareholding
6th Jul 20174:35 pmRNSPrice Monitoring Extension
29th Jun 20175:23 pmRNSDirector/PDMR Shareholding and Total Voting Rights
6th Jun 20177:00 amRNSHalf-year Report
18th May 20177:00 amRNSHalf Year Trading Update and Notice of Results
17th May 20174:31 pmRNSHolding(s) in Company
18th Apr 20173:45 pmRNSDirector/PDMR Shareholding and Total Voting Rights
7th Apr 20172:27 pmRNSDirector/PDMR Shareholding
22nd Mar 20179:22 amRNSDirector and PCA Dealing
24th Feb 201712:53 pmRNSResult of AGM
24th Feb 20177:00 amRNSAGM Trading Update
15th Feb 20172:55 pmRNSHolding(s) in Company
14th Feb 20171:24 pmRNSExercise of Options and Total Voting Rights
10th Feb 20173:39 pmRNSDirector/PDMR Shareholding
6th Feb 20176:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20179:48 amRNSDirectors' Dealing, Exercise of Options and TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.